• Multiomics Analysis of Bifendate Mechanisms in Acute Liver I

  2026-05-11

  This study leverages multiomics approaches to elucidate how bifendate (DDB) and muaddil sapra modulate gene and protein networks in acute liver injury. The work highlights bifendate’s regulation of ncRNAs and key immune/inflammation proteins, establishing new mechanistic insights for targeted hepatoprotection.

• Optimizing Cell Assays with HRP Goat Anti-Mouse IgG (H+L) An

  2026-05-10

  This article addresses persistent challenges in cell viability and immunodetection workflows, focusing on the validated use of HRP Goat Anti-Mouse IgG (H+L) Antibody (SKU K1221). Scenario-driven Q&A blocks provide actionable, evidence-based guidance for assay optimization, reproducibility, and vendor selection, supporting biomedical researchers with literature-backed best practices.

• Methylprednisolone Sodium Succinate: Advanced Bench Applicat

  2026-05-09

  Methylprednisolone Sodium Succinate empowers reproducible anti-inflammatory and immunomodulatory research, enabling precise apoptosis induction and cytokine modulation across in vitro and in vivo models. Learn advanced workflows, quantifiable protocol enhancements, and troubleshooting tips that set APExBIO’s formulation apart for inflammation and acute injury research.

• BIIE 0246: Reliable NPY Y2 Receptor Antagonism for Lab Succe

  2026-05-08

  This article presents evidence-based strategies for employing BIIE 0246 (SKU B6836) in neuropeptide Y Y2 receptor antagonist research. Drawing on validated laboratory scenarios, it demonstrates how APExBIO’s BIIE 0246 offers reproducible results, robust protocol compatibility, and superior data confidence for cell viability, proliferation, and neurocardiac studies.

• Cl-Amidine trifluoroacetate salt: Optimizing PAD4 Assays in

  2026-05-08

  Cl-Amidine (trifluoroacetate salt) empowers researchers to dissect PAD4-driven epigenetic and inflammatory mechanisms with unmatched selectivity. This guide details actionable workflows, troubleshooting strategies, and the translational leap enabled by APExBIO’s trusted reagent in cancer, autoimmunity, and septic shock models.

• PPT (Propyl Pyrazole Triol) in ERα Research: Bench to Biomar

  2026-05-07

  PPT (Propyl Pyrazole Triol) enables precision dissection of estrogen receptor alpha (ERα) signaling in both cancer biology and gene expression workflows. This article translates the latest biomarker-driven insights and troubleshooting tactics into actionable, stepwise protocols—empowering researchers to unravel ERα-mediated pathways with robust reproducibility.

• MCC950 Sodium: Precision NLRP3 Inhibition in Inflammatory Mo

  2026-05-07

  MCC950 sodium (CRID3 sodium salt) enables highly selective, nanomolar-potency inhibition of the NLRP3 inflammasome, streamlining workflows in both macrophage and endothelial experimental systems. With robust solubility, proven pathway specificity, and workflow flexibility, it empowers researchers to dissect inflammatory and autoimmune disease mechanisms with confidence.

• Radioiodinated Balsalazide: A Selective Tracer for Colitis I

  2026-05-06

  This study presents the synthesis and evaluation of radioiodinated balsalazide as a highly selective radiotracer for imaging ulcerative colitis in mice. The protocol achieves high labeling efficiency, radiochemical purity, and demonstrates strong colonic uptake in disease models, supporting advanced inflammation research workflows.

• Biochemical Functions of CARMIL’s Membrane-Binding Domain in

  2026-05-06

  This study elucidates the multifaceted regulatory mechanisms of the CARMIL membrane-binding (MB) domain in actin filament dynamics. By dissecting domain-specific actions, the authors show that the MB domain not only targets capping protein (CP) to the membrane but also modulates CP activation and release, resolving long-standing questions about actin assembly regulation at membrane interfaces.

• Tropifexor (LJN452): Potent FXR Agonist for Intestinal Barri

  2026-05-05

  Tropifexor (LJN452) is a highly potent Farnesoid X Receptor (FXR) agonist with sub-nanomolar EC50, widely used in studies of intestinal epithelial barrier function and metabolic disease models. Recent peer-reviewed research demonstrates that Tropifexor markedly improves epithelial barrier integrity and defense responses in neonatal piglets receiving parenteral nutrition. APExBIO supplies Tropifexor for research use, supporting robust FXR signaling pathway modulation.

• STING Agonist-1: Unlocking B Cell Activation in Cancer Resea

  2026-05-05

  STING agonist-1, a high-purity small molecule from APExBIO, empowers immunology and cancer researchers to dissect STING–CD40–TRAF2–IRF4 signaling and precisely modulate innate immune activation. This article provides experimental workflows, troubleshooting insights, and actionable guidance for leveraging STING agonist-1 in advanced tumor immunology studies.

• Tofacitinib Citrate: Optimized Workflows in Immune Regulatio

  2026-05-04

  Tofacitinib citrate (CP-690550 citrate) stands out for its nanomolar JAK3 selectivity, enabling precise dissection of immune pathways in inflammatory disease models. This article translates comparative endothelial findings into robust protocols, troubleshooting strategies, and advanced applications for reproducible immune regulation research.

• Reliable Cell Assays with HRP Rabbit Anti-Goat IgG (H+L) Ant

  2026-05-04

  This article provides protocol-driven insights on overcoming common immunodetection challenges in cell viability and toxicity assays. It demonstrates how the HRP Rabbit Anti-Goat IgG (H+L) Antibody (SKU K1224) from APExBIO delivers reproducible, high-sensitivity detection for goat primary antibodies. Evidence-based scenario Q&As guide selection, optimization, and interpretation in real-world laboratory settings.

• Rapamycin (Sirolimus): mTOR Inhibition for Autophagy and Lip

  2026-05-03

  Rapamycin (Sirolimus) from APExBIO delivers high specificity and reproducibility in mTOR pathway inhibition, enabling precise modulation of autophagy and lipid metabolism in both mammalian and aquatic cell models. New workflows harnessing its potent IC50 and solubility profile unlock advanced lipidomic and cell viability assays, with optimized troubleshooting strategies for complex experimental designs.

• Cy3 Goat Anti-Mouse IgG (H+L) Antibody: Technical Guidance

  2026-05-02

  The Cy3 Goat Anti-Mouse IgG (H+L) Antibody enables sensitive and specific detection of mouse immunoglobulins in immunofluorescence, flow cytometry, and western blotting workflows. It is best suited for research applications requiring fluorescence-based signal amplification, but is not intended for diagnostic or medical use. Use is not recommended where cross-reactivity with non-mouse species is a concern or when non-fluorescent detection systems are needed.

16063 records 3/1071 page Previous Next 12345 下5页 Last page